For laboratory research use only. Not for human consumption. All compounds referenced in this article are sold by Explicit SARMs solely as reference materials for in-vitro and animal research by qualified professionals. Nothing here is medical advice, and no statement has been evaluated by the FDA. These materials are not intended to diagnose, treat, cure or prevent any disease.
The BPC-157 / TB-500 Blend 10mg combines two unrelated research peptides in one lyophilized vial: 5 mg of BPC-157 and 5 mg of TB-500. This guide explains what each component is, what a fixed ratio means for study design, and how to handle and document the material.
What Is in the Vial?
- BPC-157, 5 mg: BPC-157 is a synthetic 15-amino-acid peptide whose sequence is a partial fragment of a protein originally isolated from gastric juice, often called “body protection compound.”
- TB-500, 5 mg: TB-500 is a synthetic peptide based on the actin-binding region of thymosin beta-4, a naturally occurring 43-amino-acid protein that regulates actin, the main structural protein of the cell cytoskeleton.
- Format: lyophilized powder, sold strictly as laboratory reference material.
For larger studies, the BPC-157 / TB-500 Blend 20mg contains 10 mg of each peptide in the same 1:1 ratio.
How Each Peptide Is Studied
The BPC-157 literature is largely preclinical, made up of rodent and cell-culture models, and a large share of it comes from a single research group. TB-500 is usually discussed through research on full-length thymosin beta-4, which is known for sequestering actin and is studied in cell-migration and wound-healing models. Results for the full protein don’t automatically apply to the fragment. Our BPC-157 and TB-500 research overview covers both bodies of work in more depth.
Designing Around a Fixed Ratio
A pre-mixed vial saves a preparation step and removes one source of weighing error. It also fixes the ratio, so the blend alone can’t show which component is responsible for an effect. Studies that need to attribute an effect should include single-peptide arms using BPC-157 5mg and TB-500 5mg.
Handling and Documentation
Keep the vial sealed and protected from moisture and light until use. Reconstitute with a solvent suited to your method. bacteriostatic water is a common laboratory choice. Record the lot number, solvent and date for each vial. A certificate of analysis is available on request through our contact page, and our products are purity-tested by an independent third-party lab. Our guide to reading a COA explains what each section of the report should contain. For a blend, confirm that the report identifies both peptides.
Frequently Asked Questions
Is the 10mg blend 10 mg of each peptide?
No. The 10mg blend contains 5 mg of BPC-157 and 5 mg of TB-500. The 20mg blend contains 10 mg of each.
Is the blend approved for human use?
No. It is sold strictly for laboratory research, and we do not provide dosing, administration or usage guidance. BPC-157 appears on the World Anti-Doping Agency’s prohibited list under S0 (non-approved substances). TB-500 and thymosin beta-4 appear on the World Anti-Doping Agency’s prohibited list under S2 (peptide hormones, growth factors, related substances and mimetics).